Abstract Purpose of Review This review highlights indications and evidence on laser
therapy in the management of diabetic retinopathy and diabetic macular edema. Particular …

Anti-vascular endothelial growth factor (anti-VEGF) therapy currently plays a central role in
the treatment of numerous retinal diseases, most notably exudative age-related macular …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Background: Diabetic retinopathy is a leading cause of visual impairment in working-age
adults worldwide. Duration of diabetes is a major risk factor associated with the development …

The management of diabetic retinopathy (DR) has evolved considerably over the past
decade, with the availability of new technologies (diagnostic and therapeutic). As such, the …

The elderly population in the United States is projected to almost double by the year 2050. In
addition, the numbers of diabetics are rising, along with its most common complication …

Diabetic retinopathy (DR) is a complication of diabetes and one of the leading causes of
vision loss worldwide. Despite extensive efforts to reduce visual impairment, the prevalence …

Diabetic retinopathy is the retinal disease associated with hyperglycemia in patients who
suffer from type 1 or type 2 diabetes. It includes maculopathy, involving the central retina and …

Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood
glucose, and it is a leading cause of vision loss in people with diabetes. In this review we …

Background Diabetic retinopathy (DR) is characterised by neurovascular degeneration as a
result of chronic hyperglycaemia. Proliferative diabetic retinopathy (PDR) is the most serious …